CAS NO: | 52-86-8 |
包装 | 价格(元) |
10mM (in 1mL DMSO) | 电议 |
500mg | 电议 |
1g | 电议 |
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 375.86 |
Cas No. | 52-86-8 |
Formula | C21H23ClFNO2 |
Solubility | insoluble in H2O; ≥18.79 mg/mL in DMSO; ≥2.52 mg/mL in EtOH with gentle warming and ultrasonic |
Chemical Name | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one |
Canonical SMILES | C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Haloperidol是一种抗精神病药,与抗精神病药吩噻嗪具有相似功能[1].
Haloperidol是一种多巴胺的反相激动剂.此外,Haloperidol也可抑制神经功能,从而缓解紧张,是高度有效的抗精神病药.并且,Haloperidol具有比另一种抗精神病药chiorpromazine强约50倍的效果.Haloperidol在治疗妄想和幻觉方面也有有益的效果.这些功能主要通过阻断大脑皮层和边缘系统中的多巴胺受体达成.Haloperidol可防止黑质纹状体途径中多巴胺的效果,这可能可以解释相关的副作用,如静坐不能和肌张力障碍[1].
参考文献:
[1] Dr Ananya Mandal, MD . Haloperidol Pharmacology.
Animal experiment:[1] | |
Animal models | Male Sprague-Dawley rats, 225 ~ 250 g |
Dosage form | 0, 0.01, 0.05, 0.1 or 0.5 mg/kg Administered subcutaneously |
Applications | In rats, the dopamine agonist apomorphine (APO) caused a significant decrease in prepulse inhibition (PPI) of the acoustic startle response, which could be reversed in a dose-dependent manner by haloperidol. PPI of the acoustic startle response is a measure of sensorimotor gating that is impaired in both schizophrenic patients and in rats treated with dopamine agonists. The ability of antipsychotics such as haloperidol to restore PPI in APO-treated rats correlates significantly with their clinical potency. |
Note | The technical data provided above is for reference only. |
References: 1. Swerdlow NR, Geyer MA. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 1993 Mar;44(3):741-4. |